ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 287 filers reported holding ALKERMES PLC in Q2 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $280,744 | +15.6% | 10,023 | +29.2% | 0.00% | – |
| Q2 2023 | $242,795 | +7993.2% | 7,757 | +7657.0% | 0.00% | – |
| Q1 2022 | $3,000 | -98.8% | 100 | -99.3% | 0.00% | -100.0% |
| Q1 2021 | $257,000 | -9.8% | 13,784 | -3.5% | 0.00% | 0.0% |
| Q4 2020 | $285,000 | +2.5% | 14,284 | -14.9% | 0.00% | 0.0% |
| Q3 2020 | $278,000 | -14.7% | 16,784 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $326,000 | +34.7% | 16,784 | -0.1% | 0.00% | 0.0% |
| Q1 2020 | $242,000 | -37.3% | 16,804 | -11.2% | 0.00% | 0.0% |
| Q4 2019 | $386,000 | +6.9% | 18,916 | +2.2% | 0.00% | 0.0% |
| Q3 2019 | $361,000 | -13.4% | 18,507 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $417,000 | -38.3% | 18,507 | -0.1% | 0.00% | -50.0% |
| Q1 2019 | $676,000 | +20.9% | 18,522 | -2.1% | 0.00% | 0.0% |
| Q4 2018 | $559,000 | -30.3% | 18,927 | +0.1% | 0.00% | -33.3% |
| Q3 2018 | $802,000 | +2.4% | 18,902 | -0.6% | 0.00% | 0.0% |
| Q2 2018 | $783,000 | -26.3% | 19,020 | +3.7% | 0.00% | -25.0% |
| Q1 2018 | $1,063,000 | +7.0% | 18,339 | +1.1% | 0.00% | 0.0% |
| Q4 2017 | $993,000 | +9.2% | 18,141 | +1.5% | 0.00% | 0.0% |
| Q3 2017 | $909,000 | -16.9% | 17,877 | -5.3% | 0.00% | -33.3% |
| Q2 2017 | $1,094,000 | +3.8% | 18,877 | +4.8% | 0.01% | 0.0% |
| Q1 2017 | $1,054,000 | +22.3% | 18,012 | +16.2% | 0.01% | +20.0% |
| Q4 2016 | $862,000 | +23.5% | 15,502 | +4.5% | 0.01% | +25.0% |
| Q3 2016 | $698,000 | +5.3% | 14,834 | -3.3% | 0.00% | -20.0% |
| Q2 2016 | $663,000 | +31.8% | 15,334 | +3.5% | 0.01% | +25.0% |
| Q1 2016 | $503,000 | -56.2% | 14,810 | +2.4% | 0.00% | -55.6% |
| Q4 2015 | $1,148,000 | +40.2% | 14,460 | +3.6% | 0.01% | +28.6% |
| Q3 2015 | $819,000 | -8.8% | 13,960 | 0.0% | 0.01% | -12.5% |
| Q2 2015 | $898,000 | +5.5% | 13,960 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $851,000 | -2.2% | 13,960 | -6.1% | 0.01% | -11.1% |
| Q4 2014 | $870,000 | +40.5% | 14,860 | -9.2% | 0.01% | +28.6% |
| Q3 2014 | $619,000 | -8.6% | 16,360 | +21.5% | 0.01% | -22.2% |
| Q2 2014 | $677,000 | +14.2% | 13,460 | 0.0% | 0.01% | 0.0% |
| Q1 2014 | $593,000 | +6.5% | 13,460 | -1.8% | 0.01% | -10.0% |
| Q4 2013 | $557,000 | +20.8% | 13,710 | 0.0% | 0.01% | +11.1% |
| Q3 2013 | $461,000 | +19.4% | 13,710 | +1.9% | 0.01% | 0.0% |
| Q2 2013 | $386,000 | – | 13,460 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 14,040,000 | $313,513,000 | 35.43% |
| Krensavage Asset Management, LLC | 1,411,682 | $31,523,000 | 10.04% |
| Prosight Management, LP | 502,150 | $11,213,000 | 6.01% |
| Hardman Johnston Global Advisors LLC | 5,734,259 | $128,046,000 | 5.76% |
| 13D Management LLC | 415,055 | $9,268,000 | 4.85% |
| Ally Bridge Group (NY) LLC | 300,000 | $6,699,000 | 4.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $13,248,000 | 4.25% |
| GREAT POINT PARTNERS LLC | 507,500 | $11,332,000 | 2.73% |
| Tamarack Advisers, LP | 200,000 | $4,466,000 | 2.62% |
| Zebra Capital Management LLC | 22,134 | $494,000 | 1.88% |